XML 62 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation and Capital Stock Summary of Change in Stock-Based Award Activity (Details)
9 Months Ended
Sep. 30, 2018
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 1,976,326
Granted (in shares) | shares 109,045
Exercised (in shares) | shares (829,214)
Expired (in shares) | shares (2,018)
Forfeited (in shares) | shares (59,250)
Outstanding, ending balance (in shares) | shares 1,194,889
Options exercisable, ending balance (in shares) | shares 757,276
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Beginning balance - weighted average exercise price (in dollars per share) | $ / shares $ 50.80
Granted - Weighted average exercise price (in dollars per share) | $ / shares 81.55
Exercised - Weighted average exercise price (in dollars per share) | $ / shares 49.63
Expired - Weighted average exercise price (in dollars per share) | $ / shares 63.47
Forfeited - Weighted average exercise price (in dollars per share) | $ / shares 55.94
Ending balance - weighted average exercise price (in dollars per share) | $ / shares 54.14
Options Exercisable, ending balance - Weighted average exercise price (in dollars per share) | $ / shares $ 49.59
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]  
Weighted Average Remaining Contractual Term - Outstanding, ending balance 3 years 8 months 12 days
Weighted Average Remaining Contractual Term - Options Exercisable, ending balance 3 years
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 348,876
Restricted share grants (in shares) | shares 101,325
Vested (in shares) | shares (94,981)
Forfeited (in shares) | shares (41,574)
Outstanding, ending balance (in shares) | shares 313,646
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 57.05
Granted - Weighted average grant date fair value (in dollars per share) | $ / shares 81.21
Vested - Weighted average grant date fair value (in dollars per share) | $ / shares 55.88
Forfeited - Weighted average grant date fair value (in dollars per share) | $ / shares 59.78
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 64.84
Performance Vested Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 294,204
Restricted share grants (in shares) | shares 97,490
Vested (in shares) | shares (31,048)
Forfeited (in shares) | shares (24,687)
Outstanding, ending balance (in shares) | shares 335,959
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 56.95
Granted - Weighted average grant date fair value (in dollars per share) | $ / shares 81.55
Vested - Weighted average grant date fair value (in dollars per share) | $ / shares 60.60
Forfeited - Weighted average grant date fair value (in dollars per share) | $ / shares 64.16
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 63.21